SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-057201
Filing Date
2007-03-16
Accepted
2007-03-16 16:51:11
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1136579
2 FORM OF INDEMNIFICATION AGREEMENT dex104.htm EX-10.4 2306
3 CONSENT OF KPMG LLP dex23.htm EX-23 2413
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9792
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9763
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4468
7 GRAPHIC g52509g56m28.jpg GRAPHIC 49220
  Complete submission text file 0001193125-07-057201.txt   1234697
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 07700751
SIC: 2836 Biological Products, (No Diagnostic Substances)